Abstract:Prions represent a group of proteins with a unique capacity to fold into different conformations. One isoform is rich in beta-pleated sheets and can aggregate into amyloid that may be pathogenic. This abnormal form propagates itself by imposing its confirmation on the homologous normal host cell protein. Pathogenic prions have been shown to cause lethal neurodegenerative diseases in humans and animals. These diseases are sometimes infectious and hence referred to as transmissible spongiform encephalopathies. In the present review, the remarkable evolution of the heterodox prion concept is summarized. The origin of this phenomenon is based on information transfer between homologous proteins, without the involvement of nucleic acid-encoded mechanisms. Historically, kuru and Creutzfeldt-Jakob disease (CJD) were the first infectious prion diseases to be identified in man. It was their relationship to scrapie in sheep and experimental rodents that allowed an unravelling of the particular molecular mechanism that underlie the disease process. Transmission between humans has been documented to have occurred in particular contexts, including ritual cannibalism, iatrogenic transmission because of pituitary gland-derived growth hormone or the use in neurosurgical procedures of dura mater from cadavers, and the temporary use of a prion-contaminated protein-rich feed for cows. The latter caused a major outbreak of bovine spongiform encephalopathy, which spread to man by human consumption of contaminated meat, causing approximately 200 cases of variant CJD. All these epidemics now appear to be over because of measures taken to curtail further spread of prions. Recent studies have shown that the mechanism of protein aggregation may apply to a wider range of diseases in and possibly also outside the brain, some of which are relatively common such as Alzheimer's and Parkinson's diseases. Furthermore, it has become apparent that the phenomenon of prion aggregation may have a wider physiological importance, but a full understanding of this remains to be defined. It may involve maintaining neuronal functions and possibly contributing to the establishment of long-term memory.

Expanding the Prion Paradigm to Include Alzheimer and Parkinson Diseases

Prions and protein-folding diseases

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

Aβ seeds and prions: How close the fit?

Prions Mediated Neurodegenerative Disorders.

Prion meeting 2023: implications of a growing field

The Prion Basis of Progressive Neurodegenerative Disorders

Targeting Prion-Like Protein Spreading in Neurodegenerative Diseases

Structural Variations of Prions and Prion-like Proteins Associated with Neurodegeneration

Prion-Like Mechanisms in Parkinson’s Disease

Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases

New implications for prion diseases therapy and prophylaxis

Prion-like Mechanisms in Alzheimer's Disease.

The role of α-synuclein prion strains in Parkinson's disease and multiple system atrophy

Prion science and its unsung heroes

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases

Mechanisms of prion-induced toxicity

Probing the origin of prion protein misfolding via reconstruction of ancestral proteins

The structural line between prion and "prion-like": Insights from prion protein and tau